⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL371255 | 1.00 | — | — | |
| SCHEMBL1988780 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL20775156 | 0.88 | LAP3 (0.52) | — | |
| SCHEMBL7166170 | 0.82 | LMNA (0.48) | — | |
| SCHEMBL26755328 | 0.82 | — | — | |
| SCHEMBL13607055 | 0.81 | — | — | |
| SCHEMBL7911546 | 0.77 | ALDH1A1 (0.42) | — | |
| SCHEMBL12380275 | 0.76 | — | — | |
| SCHEMBL27362930 | 0.76 | — | — | |
| SCHEMBL10077126 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11072634-B2 | Inhibitors of transglutaminases | ZEDIRA GMBH (DE) | 2021-07-27 | — | — | US | disclosed |
| US-20190322700-A1 | INHIBITORS OF TRANSGLUTAMINASES | ZEDIRA GMBH (DE) | 2019-10-24 | — | — | US | disclosed |
| US-9102708-B2 | Methods for the synthesis of dicarba bridges in organic compounds | SYNGENE LIMITED (AU) | 2015-08-11 | — | — | US | disclosed |
| US-9078930-B2 | Block copolymers for stable micelles | INTEZYNE TECHNOLOGIES, INC. (US) | 2015-07-14 | — | — | US | disclosed |
| WO-2015034920-A2 | GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR COMPOSITIONS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2015-03-12 | — | — | WO | disclosed |
| US-8575094-B2 | Use of type-B lantibiotic-based compounds having antimicrobial activity | NOVACTA BIOSYSTEMS LIMITED (GB) | 2013-11-05 | — | — | US | disclosed |
| US-8357638-B2 | Oligonucleotide library encoding randomised peptides | ASTON UNIVERSITY (GB) | 2013-01-22 | — | — | US | disclosed |
| US-8343458-B2 | Probes for in vivo targeting of active cysteine proteases | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2013-01-01 | — | — | US | disclosed |
| US-8329644-B2 | Lantibiotic-based compounds having antimicrobial activity | NOVACTA BIOSYSTEMS LIMITED (GB) | 2012-12-11 | — | — | US | disclosed |
| US-8188217-B2 | — | — | 2012-05-29 | — | — | US | disclosed |
| US-20100022749-A1 | Contoxin Analogues and Methods for Synthesizing Same | MONASH UNIVERSITY (AU) | 2010-01-28 | — | — | US | disclosed |
| US-20090264313-A1 | Oligonucleotide library encoding randomised peptides | ASTON UNIVERSITY (GB) | 2009-10-22 | — | — | US | disclosed |
| US-20090252677-A1 | Probes for In Vivo Targeting of Active Cysteine Proteases | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2009-10-08 | — | — | US | disclosed |
| US-20090203583-A1 | Use of Type-B Lantibiotic-Based Compounds having Antimicrobial Activity | NOVACTA BIOSYSTEMS LIMITED (GB) | 2009-08-13 | — | — | US | disclosed |
| US-7541143-B2 | Homo-doubly labeled compositions for the detection of enzyme activity in biological samples | ONCOIMMUNIN, INC. (US) | 2009-06-02 | — | — | US | disclosed |
| US-20080200644-A1 | Method for inverse solid phase synthesis of peptides | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2008-08-21 | — | — | US | disclosed |
| US-7307148-B2 | Method for purification of albumin conjugates | CONJUCHEM BIOTECHNOLOGIES INC. (CA) | 2007-12-11 | — | — | US | disclosed |
| US-20070280939-A1 | Prostatic Acid Phosphatase Antigens | NOTTINGHAM TRENT UNIVERSITY, THE (GB) | 2007-12-06 | — | — | US | disclosed |
| US-20070243562-A1 | Lectins for Analyzing Sugar Chains and Method of Using the Same | SUMMIT GLYCORESEARCH CORPORATION (JP) | 2007-10-18 | — | — | US | disclosed |
| US-20070231855-A1 | Functional molecule and manufacturing method therefor | FUJITSU LIMITED (JP) | 2007-10-04 | — | — | US | disclosed |